• Neuroscience & Pharmacology Discussion Welcome Guest
    Posting Rules Bluelight Rules
    Recent Journal Articles Chemistry Mega-Thread
    FREE Chemistry Databases! Self-Education Guide

  • N&PD Moderators: Skorpio | someguyontheinternet

AL-NBOMe (NBOMe analogue of Allylescaline

I shall send it forth over to ADD as they'll likely have more info for you :)
I only know it's an analogue of an analogue of Mescaline.



EADD ----> ADD

p.s. Hiyer ADD :)
 
Might be better posting somewhere rather than Europe, if it's anything like the other nbome's it's gonah take a long time to get some info on it. I remember 25c-nbome first coming out and people were eating it!
 
It is most likely it will be in the microgram range just like the others NBOMe's
 
Doubt it is active at all if it is what I think it is, i.e. N-(2-methoxybenzyl)-3,5-dimethoxy-4-allyl-PEA. NBOME mescaline is essentially inactive. I think the substitution has to be 2,5 dimethoxy for best results.

Regardless, titrating up is the best idea, ROA will probably be IM/IV > rectal > intranasal > buccal > sublingual > oral.
 
inactive? I know a vendor thats supposed to be selling this chemical soon.
 
Tell him this is a wasted effort then =D. And we have already talked about it, though I know you don't like reading archives here on bluelight.
 
To be fair, I just searched and can't find anything but this thread and one on AL. All the different ways of naming these compounds don't help.

What dose has it been taken up to? Is it less active than mescaline NBOMe?
 
The N-BOMe compounds appear to have a different binding pocket orientation than the 2C series, and so it seems that bulky 4-position substituents actually decrease affinity for 5HT2A/C.

The one I'm really curious about is the 4-F analogue, although maybe Erny and his comrades have already sampled this.
 
^^ so about the same/slightly higher potency as compared to Allylescaline itself... a decent size potency increase when you account for the differences in molecular mass. i wonder how the two compare in effects... perhaps the NBOMe- is getting cleaved metabolically and the effects of this drug are purely from Allylescaline itself? might be true, might not, but it wouldn't be the first time such a thing has happened... check out the story of MDOH in PiHKAL
 
There is this tantalizing reference in Nichols' paper on the N-benzyls: Pertz HH, Rheineck A, and Elz S (1999) N-Benzylated derivatives of the hallucinogenic drugs mescaline and escaline as partial agonists at rat vascular 5-HT2A receptors. Naunyn-Schmiedeberg’s Arch Pharmacol 359 (Suppl 3):R29. This is an abstract from a conference. Unfortunately, I haven't been able to find the abstract on Arch Pharmacol's web site.
 
Hmm, yeah it seems to just not be there, while supplements for later volumes are... I guess someone would have to order it from a library, or email him.
 
Is anyone aware of anymore information (along the lines of trip reports etc. rather than academic papers) floating around on the internet?

I have a small sample of this that I got a while back but am too busy to be able to do anything with it in the foreseeable future and would be interested in reading more anecdotal information about it in the meantime - I know I'm not the only person to have a sample so there must be more people with experiences to share!
 
You must log in or register to reply here.
Top